Monthly Archives: April 2009
Goal is to one day develop a therapy to help with spinal cord injuries
MONDAY, April 6 (HealthDay News) — Using genetically engineered cells and a virus as a delivery method, researchers were able to regenerate a type of nerve fiber in rat brains that controls movement.
This isn’t the first time researchers have shown it’s possible to re-grow some neurons responsible for movement. But the new research showed regeneration of a particular type of neuron — corticospinal motor axons — that had so far proven resistant to regeneration efforts.
“Chariots of Destiny” is a non-govermental organisation based in Nairobi, Kenya. It was started to create a much-needed difference in the transport sector for people living with physical disabilities.
The Chariots of Destiny Organization was started by Casey Marenge who through a road crash attained a spinal cord injury leaving her quadriplegic and on a wheelchair. COD has resently launched a project dubbed “Adopt a Chair”, to provide wheelchairs to the less fortunate living with disabilities in the country.
For most people, driving is a symbol of independence and freedom. It’s also often necessary for work and for obtaining the necessities of life. It helps maintain our ability to socialize or take a long-anticipated vacation.
Unfortunately, an illness or injury can sometimes make it difficult for drivers to return to the road. Fortunately, there are people who can help.
A new course of study at California State University Channel Islands this fall will train students to conduct research that could lead to cures for diabetes, spinal cord injuries or cancer.
The California Institute for Regenerative Medicine recently awarded the Camarillo-based university a threeyear, $1.7million grant to develop a master’slevel curriculum on stem cell technology and laboratory management. The institute also awarded stem cell research grants to 10 other universities this year.
ScienceDaily (Apr. 1, 2009) — Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.
Their research, published online in Annals of Neurology and led by Kimberly Byrnes, PhD, shows that inflammation following injury causes the neurotoxicity that leads to lasting nerve cell damage, and that an experimental agent is able to block this inflammatory reaction.